InsiderTrades

Form 4 for KVUE Kenvue

Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-15 · accession 0001944048-25-000226 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-12-17 2025-12-15 KVUE Tillett Caroline CSO M - OptEx $0.00 +33.9K 62.1K +121% $0
DM 2025-12-17 2025-12-15 KVUE Tillett Caroline CSO F - Tax $17.26 -17.4K 59.8K -22% -$299.6K
DM 2025-12-17 2025-12-15 KVUE Tillett Caroline CSO M - OptEx $0.00 -33.9K 6,740 -83% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-15 M A 2,994 $0.00 59,185.51 D — —
2 Common Common Stock 2025-12-15 F D 11,846 $17.28 56,191.51 D — — (F1) Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
3 Common Common Stock 2025-12-15 M A 23,158 $0.00 68,037.51 D — —
4 Common Common Stock 2025-12-15 F D 1,532 $17.28 57,653.51 D — — (F1) Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
5 Common Common Stock 2025-12-15 F D 1,725 $17.21 61,448.15 D — — (F1) Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
6 Common Common Stock 2025-12-15 M A 3,371.58 $0.00 63,173.15 D — —
7 Common Common Stock 2025-12-15 F D 2,251 $17.21 59,801.57 D — — (F1) Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
8 Common Common Stock 2025-12-15 M A 4,399.06 $0.00 62,052.57 D — —
9 Derivative Restricted Stock Units 2025-12-15 M D 4,399.06 $0.00 4,399.16 D — · — to — 4,399.06 Common Stock (F9) Includes RSUs acquired as dividend equivalents. (F7) These units correspond 1 for 1 with the Company's common stock. (F8) This award was scheduled to vest in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/05/2026 in connection with the 280G Mitigation.
10 Derivative Restricted Stock Units 2025-12-15 M D 2,994 $0.00 0 D — · — to — 2,994 Common Stock (F5) These RSUs were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. (F6) This award was scheduled to vest in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date but the vesting of the portion reflected herein was accelerated from 02/13/2026 in connection with the Section 280G Mitigation.
11 Derivative Restricted Stock Units 2025-12-15 M D 23,158 $0.00 0 D — · — to — 23,158 Common Stock (F2) These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level. (F3) This award was scheduled to vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date but vesting was accelerated in order to mitigate the adverse impact to the Issuer and the Reporting Person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Issuer and Kimberly-Clark Corporation ("Section 280G Mitigation").
12 Derivative Restricted Stock Units 2025-12-15 M D 3,371.58 $0.00 6,740.09 D — · — to — 3,371.58 Common Stock (F9) Includes RSUs acquired as dividend equivalents. (F7) These units correspond 1 for 1 with the Company's common stock. (F10) This award was scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/10/2026 in connection with the Section 280G Mitigation.